TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Swedish Orphan Biovitrum International AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
23,556
|
22,627
|
22,877 |
Financial expenses |
93,892
|
92,986
|
95,168 |
Earnings before taxes |
-65,975
|
-90,331
|
-145,394 |
EBITDA |
22,215
|
1,240
|
-29,792 |
Total assets |
5,712,236
|
5,682,974
|
5,643,659 |
Current assets |
34,902
|
399,379
|
184,854 |
Current liabilities |
104,582
|
14,093
|
15,835 |
Equity capital |
1,414,464
|
1,167,762
|
1,050,022 |
- share capital |
630
|
588
|
607 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.8%
|
20.5%
|
18.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-280.1%
|
-399.2%
|
-635.5% |
Return on assets (ROA) |
0.5%
|
0.0%
|
-0.9% |
Current ratio |
33.4%
|
2833.9%
|
1167.4% |
Return on equity (ROE) |
-4.7%
|
-7.7%
|
-13.8% |
Change turnover |
-677
|
438
|
-10,243 |
Change turnover % |
-3%
|
2%
|
-31% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.